- Home
- EPOW vs UNCY Comparison
EPOW vs UNCY Comparison
Compare EPOW & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- UNCY
- Stock Information
- Founded
- EPOW 2014
- UNCY 2016
- Country
- EPOW China
- UNCY United States
- Employees
- EPOW N/A
- UNCY N/A
- Industry
- EPOW Business Services
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- EPOW Consumer Discretionary
- UNCY Health Care
- Exchange
- EPOW Nasdaq
- UNCY Nasdaq
- Market Cap
- EPOW 27.2M
- UNCY 31.9M
- IPO Year
- EPOW 2021
- UNCY 2021
- Fundamental
- Price
- EPOW $1.13
- UNCY $0.35
- Analyst Decision
- EPOW
- UNCY Strong Buy
- Analyst Count
- EPOW 0
- UNCY 4
- Target Price
- EPOW N/A
- UNCY $5.13
- AVG Volume (30 Days)
- EPOW 107.3K
- UNCY 3.8M
- Earning Date
- EPOW 09-17-2024
- UNCY 08-14-2024
- Dividend Yield
- EPOW N/A
- UNCY N/A
- EPS Growth
- EPOW N/A
- UNCY N/A
- EPS
- EPOW N/A
- UNCY N/A
- Revenue
- EPOW $45,050,405.00
- UNCY N/A
- Revenue This Year
- EPOW N/A
- UNCY N/A
- Revenue Next Year
- EPOW N/A
- UNCY N/A
- P/E Ratio
- EPOW N/A
- UNCY N/A
- Revenue Growth
- EPOW 18.16
- UNCY N/A
- 52 Week Low
- EPOW $0.53
- UNCY $0.20
- 52 Week High
- EPOW $2.15
- UNCY $1.82
- Technical
- Relative Strength Index (RSI)
- EPOW 74.42
- UNCY 46.57
- Support Level
- EPOW $0.93
- UNCY $0.28
- Resistance Level
- EPOW $1.07
- UNCY $0.37
- Average True Range (ATR)
- EPOW 0.06
- UNCY 0.04
- MACD
- EPOW 0.00
- UNCY 0.01
- Stochastic Oscillator
- EPOW 90.78
- UNCY 57.34
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is into the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.